文献速递免疫规划卫生政策与健康促进

澳大利亚老年人RSV疫苗接种的社会经济不平等

Unequal access: Respiratory syncytial virus vaccine uptake by socioeconomic status among older adults in Australia.
PubMed 文献 · Vaccine · 2026-02-24

该横断面研究基于FluTracking参与者,纳入10376名≥75岁澳大利亚居民,评估RSV、流感和COVID-19疫苗接种率在不同社会经济地位(SES)间的差异。结果显示RSV接种率仅19.6%,低于流感(92.5%)和COVID-19(67.1%);中、低SES组相比高SES组三种疫苗的接种 odds 均更低,且RSV的差异最明显。

要点

  • ≥75岁人群中RSV疫苗接种率仅19.6%,远低于流感92.5%和COVID-19 67.1%。
  • 中SES组较高SES组RSV接种 odds 低42.3%,低SES组低47.1%。
  • RSV接种的社会经济梯度比流感、COVID-19更显著。

核心结论

  • ≥75岁老年人RSV疫苗接种率低于流感与COVID-19。
  • 中、低SES组三种疫苗接种 odds 均低于高SES组,RSV差异最明显。

研究设计与样本

  • 横断面研究,纳入10376名≥75岁FluTracking参与者,SES按居住邮编匹配IRSAD分配。

主要发现

  • RSV接种率19.6%,流感92.5%,COVID-19 67.1%。
  • 中SES组较高SES组RSV、流感、COVID-19接种 odds 分别低42.3%、19.8%、24.0%。
  • 低SES组较高SES组RSV、流感、COVID-19接种 odds 分别低47.1%、35.1%、30.2%。

临床怎么用

  • 关注≥75岁老年人RSV疫苗接种,尤其低SES人群的接种公平性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Respiratory Syncytial Virus (RSV) vaccination was first approved by the Therapeutic Goods Administration of Australia for older adults in January 2024. We aimed to evaluate uptake among people aged ≥75 years across different socioeconomic thresholds. METHODS: Male and female FluTracking participants were included in this cross-sectional study if they had an Australian residential postcode documented, returned at least one weekly survey between 30 March 2025 and 2 December 2025 while aged ≥75 years, and had a recently documented RSV, influenza, and COVID-19 vaccination status. Socioeconomic status (SES) was allocated by matching participant residential postcode to the Index of Relative Socio-economic Disadvantage for that postcode. Relative difference in vaccine uptake across SES categories was evaluated using logistic regression. RESULTS: A total of 10,376 participants were included (61.4% aged 75-79 years, 54.2% female). High, medium, and low SES categories were represented by 5347 (51.5%), 3658 (35.3%), and 1371 (13.2%) participants, respectively. Recent RSV vaccination was reported by 19.6% of participants, recent influenza vaccination by 92.5%, and recent COVID-19 vaccination by 67.1%. In age, sex, and state/territory adjusted analyses, the odds of vaccination in the medium compared with the high SES group for RSV, influenza, and COVID-19 were 42.3%, 19.8%, and 24.0% lower, respectively. The adjusted odds of vaccination in the low SES group compared with the high SES group for RSV, influenza, and COVID-19 were 47.1%, 35.1%, and 30.2% lower, respectively. CONCLUSION: We found lower uptake of RSV vaccination among adults aged ≥75 years compared with recent vaccination for influenza and COVID-19. Lower SES groups had lower uptake of all three vaccines compared with the high SES group and the relative difference in uptake across socioeconomic levels were more pronounced for RSV vaccination. Broad public funding for RSV vaccination among older adults in Australia could help to reduce inequity in uptake.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Boettiger DC, Carlson SJ, Adams SR, et al. Unequal access: Respiratory syncytial virus vaccine uptake by socioeconomic status among older adults in Australia. Vaccine. 2026. PMID: 41740460. doi:10.1016/j.vaccine.2026.128395

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。